Sign in to continue:

Monday, July 27th, 2026

China Tontine Wines Announces HK$8.75 Million Share Placement Under General Mandate to Strengthen Financial Position and Repay Borrowings 125





China Tontine Wines Group Limited Placing Announcement – Investor Report

China Tontine Wines Group Limited Announces Placing of New Shares Under General Mandate

Key Highlights for Investors

  • Placing of Shares: The company has entered into a Placing Agreement to issue up to 60,312,360 new shares at HK\$0.145 per share. This represents 20% of the current issued share capital and 16.67% of the enlarged share capital post-placing.
  • Placing Price Discount: The placing price is at an 18.99% discount to the closing price of HK\$0.179 (24 July 2026), and a 9.38% discount to the average closing price over the preceding five trading days (HK\$0.160).
  • Gross and Net Proceeds: If fully placed, gross proceeds will be HK\$8.75 million, with estimated net proceeds (after HK\$0.37 million expenses) of HK\$8.38 million.
  • Use of Proceeds: The company plans to use:
    • 80% (~HK\$6.70 million) to repay outstanding borrowings and interest.
    • 10% (~HK\$0.84 million) for legal and professional expenses and payables.
    • 10% (~HK\$0.84 million) to replenish general working capital (staff costs, rental, operating expenses).
  • Shareholding Structure Impact: Upon completion, Placees will hold 16.67% of the enlarged share capital. Existing major shareholders’ stakes will be diluted but not below the threshold for substantial shareholders.
  • No Shareholder Approval Required: Shares are issued under the General Mandate and do not require further shareholder approval.
  • Potentially Price Sensitive Events: The dilution effect, discounted placing price, and improved liquidity/financial position may impact share prices and trading activity.
  • Placing Agent & Terms: Minerva Holding Financial Securities Limited is the placing agent, entitled to a 2.5% commission. The terms are deemed fair and reasonable after negotiation.
  • Completion Conditions: Placing is subject to approval by the Stock Exchange for listing the new shares, and all necessary consents being obtained. The placing agent has termination rights under specified adverse events (e.g., market turmoil, breach of warranties, changes in market conditions, suspension of trading).
  • Financial Context: As at 31 December 2025, the group had RMB15.89 million in outstanding borrowings, which underscores the need for this capital raise.
  • No Recent Fund Raising: The company has not conducted any other fund raising activities involving equity in the past 12 months.
  • Board Composition: The announcement lists the current executive, non-executive, and independent non-executive directors.

Investor Analysis & Implications

This placing is a significant corporate action for China Tontine Wines Group Limited, as it enables the company to raise additional funds without shareholder approval, directly addressing its outstanding liabilities and bolstering its financial stability. The large size (up to 20% of current share capital), the discounted price, and the broadening of the shareholder base may affect share price and liquidity. Investors should note the dilution effect, especially major shareholders, and monitor the completion risks associated with the conditions precedent and placing agent’s termination rights.

The company expects the proceeds to improve its gearing ratio, provide working capital, and enhance trading liquidity by expanding the shareholder base. Given the substantial discount to the prevailing market price and the strategic use of proceeds, this news is likely to be price sensitive and merits close attention from current and potential shareholders.

Disclaimer

The above article is for informational purposes only and does not constitute investment advice. Investors are reminded that completion of the placing is subject to conditions and may not proceed. Please exercise caution and consult your financial adviser before making investment decisions based on this announcement.


中國通天酒業集團有限公司配售新股份公告(投資者報導)

投資者重點

  • 股份配售: 公司已簽訂配售協議,將發行最多60,312,360新股份,每股配售價為HK\$0.145。配售股份佔現有已發行股本的20%,配售後擴大股本的16.67%
  • 配售價折讓: 配售價較2026年7月24日收市價HK\$0.179折讓18.99%,較過去五個交易日平均收市價HK\$0.160折讓9.38%
  • 集資金額: 若全部配售,總集資約HK\$8.75百萬,扣除配售費用HK\$0.37百萬後,淨集資約HK\$8.38百萬
  • 資金用途:
    • 80%(約HK\$6.70百萬)用於償還集團未償借款及利息。
    • 10%(約HK\$0.84百萬)用於支付法律及專業費用及應付款。
    • 10%(約HK\$0.84百萬)補充集團一般營運資金(員工薪酬、租金、經營開支)。
  • 股權結構變動: 配售完成後,配售對象將持有擴大股本的16.67%。現有主要股東持股會被稀釋,但不會跌至實質股東以下。
  • 無需股東批准: 配售股份將根據一般授權發行,無需股東進一步批准。
  • 可能影響股價事項: 股份稀釋、配售價折讓、流動性提升及財務狀況改善均可能影響股價及交易。
  • 配售代理及條款: 配售代理為Minerva Holding Financial Securities Limited,佣金為2.5%。條款經協商,被認為合理。
  • 配售完成條件: 配售需獲聯交所批准股份上市及所有必要同意。配售代理於特定情況(如市場動盪、公司違反保證、重大市場變動、股份停牌)有終止權。
  • 財務背景: 截至2025年12月31日,集團未償借款約RMB15.89百萬,突顯集資需要。
  • 近期無其他集資: 過去12個月公司未有其他涉及股本集資活動。
  • 董事會組成: 公告列明現任執行、非執行及獨立非執行董事。

投資者分析及影響

今次配售是中國通天酒業集團重要企業舉措,無需股東批准即可集資,直接解決未償負債,強化財務。配售規模大(佔現有股本20%)、配售價折讓及股東基礎擴大,均可能影響股價及流動性。投資者須留意股份稀釋,特別是主要股東,並關注配售完成風險(條件先決及代理終止權)。

公司預期集資將改善資本結構、提供營運資金,且配售有助提升股份流動性。由於配售價明顯折讓及資金用途具策略性,此消息具明顯價格敏感性,現有及潛在股東應高度關注。

免責聲明

以上文章僅供資訊參考,不構成任何投資建議。投資者須留意配售完成需先決條件,未必一定完成。請謹慎操作,並在作出投資決定前諮詢財務顧問。




View TONTINE WINES Historical chart here



Biocytogen Pharmaceuticals Clarifies Credit Facility and Guarantee Details in 2026 AGM Announcement

Biocytogen Pharmaceuticals Clarification Announcement – Inve...

BAIOO Family Interactive Limited Chairman Purchases Shares: Director’s Dealings Announcement April 2026

BAIOO Family Interactive Limited – Director’s Share Purchase...